The subcutaneous drug delivery devices market was valued at US$ 9,243.80 million in 2018 and it is projected to reach US$ 17,290.47 million in 2027; it is expected to grow at a CAGR of 7.4% from 2019 to 2027.
Subcutaneous drug delivery refers to a process that involves administration of medication or medicine under the skin. In the subcutaneous drug delivery process, a small needle is used to inject the drug in the tissue present in between muscle and skin. The drug is usually injected in low volumes, which varies between 1 mL to 2mL. For instance, insulin is widely administered through subcutaneous injection. The abdomen, arm, and thigh are the most common injection sites for subcutaneous injection. The growth of the global subcutaneous drug delivery devices market is attributed to the increased number of chronic disease, increasing R&D expenditures in pharmaceutical and medical device companies and technological advancements and increasing product launches. However, risk of infections and other diseases associated with the use of injections and syringes is the major factor hindering the market growth.
The global subcutaneous drug delivery devices market is expected to witness substantial growth post-pandemic. The COVID-19 has affected economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. The COVID-19 crisis has overburdened public health systems in many countries and highlighted the strong need for sustainable investment in health systems. As the COVID-19 pandemic progresses, the healthcare industry is expected to see a drop in growth. The life sciences segment thrives due to increased demand for invitro diagnostic products and rising research and development activities worldwide. However, the medical technologies and imaging segment is witnessing drop in sales due to a smaller number of surgeries being carried out and delayed or prolonged equipment procurement. Additionally, virtual consultations by healthcare professionals are expected to become the mainstream care delivery model post-pandemic. With telehealth transforming care delivery, digital health will continue to thrive in coming years. In addition, disrupted clinical trials and the subsequent delay in drug launches is also expected to pave the way for entirely virtual trials in the future. New technologies such as mRNA is expected to emerge and shift the pharmaceutical industry and market is also expected to witness more vertical integration and joint ventures in coming years.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Subcutaneous Drug Delivery Devices Market: Strategic Insights
Market Size Value in US$ 9,243.80 Million in 2018 Market Size Value by US$ 17,290.47 Million by 2027 Growth rate CAGR of 7.4% from 2019-2027 Forecast Period 2019-2027 Base Year 2019
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Subcutaneous Drug Delivery Devices Market: Strategic Insights
| Market Size Value in | US$ 9,243.80 Million in 2018 |
| Market Size Value by | US$ 17,290.47 Million by 2027 |
| Growth rate | CAGR of 7.4% from 2019-2027 |
| Forecast Period | 2019-2027 |
| Base Year | 2019 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Market Insights
Increasing R&D Expenditures in Pharmaceutical and Medical Device Companies to Drive Global Subcutaneous Drug Delivery Devices Market Growth
Research and development (R&D) is an essential and crucial part of the company’s business. Pharmaceutical and medical devices companies focus on the research and development (R&D) to come up with new molecules for various therapeutic applications with the greatest medical and commercial potential. The companies invest majorly on the R&Ds with the aim of delivering high quality and innovative products to the market.
R&D spending by the biopharmaceutical companies has also increased over the years. According to a report of Pharmaceutical Research and Manufacturers of America (PhRMA), the R&D expenditure of the biopharmaceutical companies has increased from US$49.6 billion 2012 to US$ 58.8 billion in 2015. Also, Evonik Corporation has invested more than $50 million over the last 4 years to advance its competencies in medical devices, and production of RESOMER polymers for drug delivery and bio reabsorbable medical devices.
Thus the growing R&D expenditure drives the subcutaneous drug delivery systems market during the forecast period.
Technology -Based Insights
In terms of technology, the global subcutaneous drug delivery devices market is segmented into syringes, pens, patches and others. In 2018, the syringes segment held largest share of the market. However, the patches segment is estimated to grow at the fastest rate during the forecast period.
Syringe Type-Based Insights
In terms of syringe type, the global subcutaneous drug delivery devices market is segmented into prefilled injectable and fillable injectable. In 2018, the fillable injectable segment held largest share of the market. However, the prefilled injectable segment is expected to register the highest CAGR during the forecast period.
Subcutaneous Drug Delivery Devices Market Report Scope
Distribution Channel-Based Insights
In terms of distribution channel, the global subcutaneous drug delivery devices market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacies segment held the largest share of the market in 2018, and the same segment is estimated to grow at the fastest rate during the forecast period.
The global subcutaneous drug delivery devices market players are adopting the product launch and expansion strategies to cater to changing customer demands worldwide, which also allows them to maintain their brand name globally.
Global Subcutaneous Drug Delivery Devices Market – by Technology
- Syringes
- Pens
- Patches
- Others
Global Subcutaneous Drug Delivery Devices Market – by Syringe Type
- Prefilled Injectable
- Fillable Injectable
Global Subcutaneous Drug Delivery Devices Market – by Distribution Channel
- Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
Global Subcutaneous Drug Delivery Devices Market – by Geography
- North America
- US
- Canada
- Mexico
- Europe
- France
- Germany
- Italy
- UK
- Spain
- Rest of Europe
- Asia Pacific (APAC)
- China
- India
- South Korea
- Japan
- Australia
- Rest of APAC
- Middle East & Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Rest of MEA
- South America and Central America (SCAM)
- Brazil
- Argentina
- Rest of SCAM
Company Profiles
- Insulet Corporation
- BD
- Enable Injections
- Consort Medical Plc
- West Pharmaceutical Services, Inc.
- Elcam Medical
- Amgen
- Ypsomed AG
- SCPharmaceuticals, Inc.
- Wilhelm Haselmeier GmbH & Co. KG
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Technology ; Syringe Type ; Distribution Channel and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
US, Canada, Mexico, UK, Germany, Spain, Italy, France, India, China, Japan, South Korea, Australia, UAE, Saudi Arabia, South Africa, Brazil, Argentina
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Subcutaneous Drug Delivery Devices Market – By Technology
1.3.2 Global Subcutaneous Drug Delivery Devices Market – By Syringe Type
1.3.3 Global Subcutaneous Drug Delivery Devices Market – By Distribution Channel
1.3.4 Global Subcutaneous Drug Delivery Devices Market – By Geography
2. Global Subcutaneous Drug Delivery Devices Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Global Subcutaneous Drug Delivery Devices– Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific – PEST Analysis
4.2.4 Middle East & Africa– PEST Analysis
4.2.5 South & Central America – PEST Analysis
4.3 Expert Opinions
5. Global Subcutaneous Drug Delivery Devices Market – Key Industry Dynamics
5.1.1 Increasing Incidence of Chronic Diseases
5.1.2 Increasing R&D Expenditures in Pharmaceutical And Medical Device Companies
5.1.3 Technological Advancements and Increasing Product Launches
5.2 Key Market Restraints
5.2.1 Risks Associated with Injections:
5.3 Key Market Opportunities
5.3.1 Development of Products As Per Patient Compliance
5.4 Future Trends
5.4.1 Growing Product Innovations through Collaborative Research:
5.4.2 Rapid Adoption of Pre-Filled Saline Syringes
5.5 Impact Analysis
6. Subcutaneous Drug Delivery Devices Market – Global Analysis
6.1 Global Subcutaneous Drug Delivery Devices Market Revenue Forecasts And Analysis
6.2 Global Subcutaneous Drug Delivery Devices Market, By Geography - Forecasts And Analysis
6.3 Market Positioning of Key Players
7. Subcutaneous Drug Delivery Devices Market Analysis And Forecasts To 2027 – Technology
7.1 Overview
7.2 Global Subcutaneous Drug Delivery Devices Market Share by Technology 2018 & 2027 (%)
7.3 Syringes Market
7.3.1 Overview
7.3.2 Syringes Market Revenue and Forecast to 2027 (US$ Mn)
7.3.3 Pens
7.3.3.1 Overview
7.3.3.2 Pens Market Revenue and Forecast to 2027 (US$ Mn)
7.3.4 Patches
7.3.4.1 Overview
7.3.4.2 Patches Market Revenue and Forecast to 2027 (US$ Mn)
7.3.5 Others
7.3.5.1 Overview
7.3.5.2 Others Market Revenue and Forecast to 2027 (US$ Mn)
8. Subcutaneous Drug Delivery Devices Market Analysis And Forecasts To 2027 – Syringe Type
8.1 Overview
8.2 Global Subcutaneous Drug Delivery Devices Market Share by Syringe Type 2018 & 2027 (%)
8.3 Prefilled Injectable Market
8.3.1 Overview
8.3.2 Prefilled Injectable Market Revenue and Forecast to 2027 (US$ Mn)
8.4 Fillable Injectable Market
8.4.1 Overview
8.4.2 Fillable Injectable Market Revenue and Forecast to 2027 (US$ Mn)
9. Subcutaneous Drug Delivery Devices Market Analysis And Forecasts To 2027 – Distribution Channel
9.1 Overview
9.2 Global Subcutaneous Drug Delivery Devices Market Share by Distribution Channel 2018 & 2027 (%)
9.3 Hospital Pharmacies Market
9.3.1 Overview
9.3.2 Hospital Pharmacies Market Revenue and Forecast to 2027 (US$ Mn)
9.4 Retail Pharmacies Market
9.4.1 Overview
9.4.2 Retail Pharmacies Market Revenue and Forecast to 2027 (US$ Mn)
9.5 Online Pharmacies Market
9.5.1 Overview
9.5.2 Online Pharmacies Market Revenue and Forecast to 2027 (US$ Mn)
10. Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 – Geographical Analysis
10.1 North America Subcutaneous Drug Delivery Devices Market Revenue And Forecasts To 2027
10.1.1 North America Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
10.2 North America Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.3 North America Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
10.4 North America Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
10.4.1 North America Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027, By Country (%)
10.4.2 US Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
10.4.2.1 US Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
10.4.2.2 US Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.4.2.3 US Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
10.4.2.4 US Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
10.4.3 Canada Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
10.4.3.1 Canada Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
10.4.3.2 Canada Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.4.3.3 Canada Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
10.4.3.4 Canada Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
10.4.4 Mexico Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
10.4.4.1 Mexico Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
10.4.4.2 Mexico Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.4.4.3 Mexico Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
10.4.4.4 Mexico Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
10.5 Europe Subcutaneous Drug Delivery Devices Market Revenue And Forecasts To 2027
10.5.1 Europe Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
10.6 Europe Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.7 Europe Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
10.8 Europe Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
10.8.1 Europe Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027, By Country (%)
10.8.2 UK Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
10.8.2.1 UK Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
10.8.2.2 UK Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.8.2.3 UK Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
10.8.2.4 UK Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
10.8.3 Germany Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
10.8.3.1 Germany Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
10.8.3.2 Germany Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.8.3.3 Germany Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
10.8.3.4 Germany Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
10.8.4 France Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
10.8.4.1 France Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
10.8.4.2 France Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.8.4.3 France Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
10.8.4.4 France Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
10.8.5 Italy Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
10.8.5.1 Italy Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
10.8.5.2 Italy Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.8.5.3 Italy Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
10.8.5.4 Italy Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
10.8.6 Spain Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
10.8.6.1 Spain Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
10.8.6.2 Spain Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.8.6.3 Spain Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
10.8.6.4 Spain Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
11. Asia Pacific Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027
11.1 Overview
11.2 Asia Pacific Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
11.3 Asia Pacific Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.4 Asia Pacific Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
11.5 Asia Pacific Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
11.6 Asia Pacific Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027, By Country (%)
11.7 Japan Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
11.7.1 Japan Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
11.7.1.1 Japan Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.7.1.2 Japan Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
11.7.1.3 Japan Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
11.8 China Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
11.8.1 China Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
11.8.1.1 China Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.8.1.2 China Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
11.8.1.3 China Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
11.9 India Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
11.9.1 India Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
11.9.1.1 India Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.9.1.2 India Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
11.9.1.3 India Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
11.10 Australia Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
11.10.1 Australia Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
11.10.1.1.. Australia Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.10.1.2.. Australia Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
11.10.1.3.. Australia Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
11.11 South Korea Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
11.11.1 South Korea Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
11.11.1.1... South Korea Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
11.11.1.2... South Korea Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
11.11.1.3... South Korea Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
12. Middle East & Africa Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027
12.1 Overview
12.2 Middle East & Africa Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
12.3 Middle East and Africa Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
12.4 Middle East and Africa Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
12.5 Middle East and Africa Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
12.6 Middle East & Africa Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027, By Country (%)
12.7 South Africa Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
12.7.1 South Africa Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
12.7.1.1 South Africa Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
12.7.1.2 South Africa Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
12.7.1.3 South Africa Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
12.8 Saudi Arabia Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
12.8.1 Saudi Arabia Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
12.8.1.1 Saudi Arabia Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
12.8.1.2 Saudi Arabia Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
12.8.1.3 Saudi Arabia Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
12.9 UAE Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
12.9.1 UAE Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
12.9.1.1 UAE Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
12.9.1.2 UAE Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
12.9.1.3 UAE Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
13. South and Central America Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027
13.1 Overview
13.2 South and Central America Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
13.3 South and Central America Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
13.4 South and Central America Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
13.5 South and Central America Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
13.6 South and Central America Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027, By Country (%)
13.7 Brazil Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
13.7.1.1 Brazil Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
13.7.1.2 Brazil Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
13.7.1.3 Brazil Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
13.7.1.4 Brazil Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
13.7.2 Argentina Subcutaneous Drug Delivery Devices Market
13.7.2.1 Argentina Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
13.7.2.2 Argentina Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
13.7.2.3 Argentina Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
13.7.2.4 Argentina Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
14. Subcutaneous Drug Delivery Devices Market – Industry Landscape
14.1 Overview
14.2 Growth Strategies done by the companies in the Market, (%)
14.3 Organic Developments
14.3.1 Overview
14.4 Inorganic developments
14.4.1 Overview
15. Subcutaneous Drug Delivery Devices Market – Key Company Profiles
15.1 Insulet Corporation
15.1.1 Key Facts
15.1.2 Business Description
15.1.3 Financial Information
15.1.4 Product Portfolio
15.1.5 SWOT Analysis
15.1.6 Key Developments
15.2 BD
15.2.1 Key Facts
15.2.2 Business Description
15.2.3 Financial Overview
15.2.4 Product Portfolio
15.2.5 SWOT Analysis
15.2.6 Key Developments
15.3 Amgen Inc.
15.3.1 Key Facts
15.3.2 Business Description
15.3.3 Financial Overview
15.3.4 Product Portfolio
15.3.5 SWOT Analysis
15.3.6 Key Developments
15.4 ELCAM Medical
15.4.1 Key Facts
15.4.2 Business Description
15.4.3 Financial Overview
15.4.4 Product Portfolio
15.4.5 SWOT Analysis
15.4.6 Key Developments.
15.5 Ypsomed AG
15.5.1 Key Facts
15.5.2 Business Description
15.5.3 Financial Information
15.5.4 Product Portfolio
15.5.5 SWOT Analysis
15.5.6 Key Developments
15.6 West Pharmaceutical Services, Inc
15.6.1 Key Facts
15.6.2 Business Description
15.6.3 Financial Information
15.6.4 Product Portfolio
15.6.5 SWOT Analysis
15.6.6 Key Developments
15.7 Scpharmaceuticals, Inc.
15.7.1 Key Facts
15.7.2 Business Description
15.7.3 Financial Overview
15.7.4 Product Portfolio
15.7.5 SWOT Analysis
15.7.6 Key Developments.
15.8 Wilhelm Haselmeier GmbH and Co. KG
15.8.1 Key Facts
15.8.2 Business Description
15.8.3 Financial Overview
15.8.4 Product Portfolio
15.8.5 SWOT Analysis
15.8.6 Key Developments
15.9 Consort Medical PLC
15.9.1 Key Facts
15.9.2 Business Description
15.9.3 Financial Overview
15.9.4 Product Portfolio
15.9.5 SWOT Analysis
15.9.6 Key Developments
15.10 Enable Injections, Inc.
15.10.1 Key Facts
15.10.2 Business Description
15.10.3 Financial Overview
15.10.4 Product Portfolio
15.10.5 SWOT Analysis
15.10.6 Key Developments
16. Appendix
16.1 About The Insight Partners
16.2 Glossary Of Terms
LIST OF TABLES
Table 1. R&D Investments by Major Pharmaceutical Companies
Table 2. North America Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 3. North America Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
Table 4. North America Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
Table 5. US Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 6. US Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
Table 7. US Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
Table 8. Canada Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 9. Canada Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
Table 10. Canada Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
Table 11. Mexico Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 12. Mexico Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
Table 13. Mexico Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
Table 14. Europe Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 15. Europe Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
Table 16. Europe Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
Table 17. UK Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 18. UK Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
Table 19. UK Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
Table 20. Germany Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 21. Germany Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
Table 22. Germany Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
Table 23. France Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 24. France Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
Table 25. France Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
Table 26. Italy Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 27. Italy Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
Table 28. Italy Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
Table 29. Spain Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 30. Spain Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
Table 31. Spain Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
Table 32. Asia Pacific Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 33. Asia Pacific Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
Table 34. Asia Pacific Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
Table 35. Japan Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 36. Japan Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
Table 37. Japan Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
Table 38. China Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 39. China Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
Table 40. China Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
Table 41. India Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 42. India Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
Table 43. India Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
Table 44. Australia Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 45. Australia Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
Table 46. Australia Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
Table 47. South Korea Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 48. South Korea Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
Table 49. South Korea Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
Table 50. Middle East and Africa Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 51. Middle East and Africa Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
Table 52. Middle East and Africa Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
Table 53. South Africa Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 54. South Africa Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
Table 55. South Africa Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
Table 56. Saudi Arabia Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 57. Saudi Arabia Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
Table 58. Saudi Arabia Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
Table 59. UAE Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 60. UAE Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
Table 61. UAE Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
Table 62. South and Central America Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 63. South and Central America Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
Table 64. South and Central America Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
Table 65. Brazil Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 66. Brazil Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
Table 67. Brazil Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
Table 68. Argentina Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 69. Argentina Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Syringe Type (US$ Mn)
Table 70. Argentina Subcutaneous Drug Delivery Devices Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
Table 71. Organic Developments Done By Companies
Table 72. Inorganic developments done by Companies
Table 73. Glossary Of Terms, Subcutaneous Drug Delivery Devices Market
LIST OF FIGURES
Figure 1. Subcutaneous Drug Delivery Devices Market Segmentation
Figure 2. Subcutaneous Drug Delivery Devices Segmentation, By Region
Figure 3. Global Subcutaneous Drug Delivery Devices Market Overview
Figure 4. Fillable Injectable Segment Held Largest Share Of The Syringe Type Segment In Subcutaneous Drug Delivery Devices Market
Figure 5. North America Region Is Expected To Show Remarkable Growth During The Forecast Period
Figure 6. Global Subcutaneous Drug Delivery Devices Market, By Geography (US$ Mn)
Figure 7. Global Subcutaneous Drug Delivery Devices Market- Leading Country Markets (US$ Mn)
Figure 8. Global Subcutaneous Drug Delivery Devices Market, Industry Landscape
Figure 9. North America : PEST Analysis
Figure 10. Europe: PEST Analysis
Figure 11. Asia Pacific PEST Analysis
Figure 12. Middle East & Africa PEST Analysis
Figure 13. South & Central America PEST Analysis
Figure 14. Global Subcutaneous Drug Delivery Devices Market – Revenue Forecasts And Analysis – 2018- 2027
Figure 15. Global Subcutaneous Drug Delivery Devices Market – By Geography Forecasts And Analysis – 2018- 2027
Figure 16. Global Subcutaneous Drug Delivery Devices Market – Market Positioning
Figure 17. Global Subcutaneous Drug Delivery Devices Market Share By Technology 2018 & 2027 (%)
Figure 18. Syringes Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 19. Pens Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 20. Patches Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 21. Others Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 22. Global Subcutaneous Drug Delivery Devices Market Share by Syringe Type 2018 & 2027 (%)
Figure 23. Prefilled Injectable Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 24. Fillable Injectable Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 25. Global Subcutaneous Drug Delivery Devices Market Share by Distribution Channel 2018 & 2027 (%)
Figure 26. Hospital Pharmacies Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 27. Retail Pharmacies Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 28. Online Pharmacies Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 29. North America Subcutaneous Drug Delivery Devices Market Revenue Overview, by Country, 2018 (US$ Mn)
Figure 30. North America Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 31. North America Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027, By Country (%)
Figure 32. US Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 33. Canada Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 34. Mexico Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 35. Europe Subcutaneous Drug Delivery Devices Market Revenue Overview, by Country, 2018 (US$ MN)
Figure 36. Europe Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 37. Europe Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027, By Country (%)
Figure 38. UK Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 39. Germany Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 40. France Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 41. Italy Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 42. Spain Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 43. Asia Pacific Subcutaneous Drug Delivery Devices Market Overview, by Country (2017)
Figure 44. Asia Pacific Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 45. Asia Pacific Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027, By Country (%)
Figure 46. Japan Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 47. China Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 48. India Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 49. Australia Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 50. South Korea Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 51. Middle East & Africa Subcutaneous Drug Delivery Devices Market Overview, by Country (2018)
Figure 52. Middle East & Africa Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 53. Middle East & Africa Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027, By Country (%)
Figure 54. South Africa Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 55. Saudi Arabia Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 56. UAE Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 57. South and Central America Subcutaneous Drug Delivery Devices Market Overview, by Country (2018)
Figure 58. South and Central America Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 59. South and Central America Subcutaneous Drug Delivery Devices Market Revenue and Forecasts to 2027, By Country (%)
Figure 60. Brazil Subcutaneous Drug Delivery Devices Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 61. Argentina Subcutaneous Drug Delivery Devices Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 62. Growth Strategies done by the companies in the Market, (%)
The List of Companies - Subcutaneous Drug Delivery Devices Market
- Insulet Corporation
- BD
- Enable Injections
- Consort Medical Plc
- West Pharmaceutical Services, Inc.
- Elcam Medical
- Amgen
- Ypsomed AG
- SCPharmaceuticals, Inc.
- Wilhelm Haselmeier GmbH & Co. KG
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Subcutaneous Drug Delivery Devices Market
Sep 2019
Mobile Cleanroom Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Softwall and Hardwall), End User (Microelectronics Industry, Pharmaceuticals and Biotechnology Industry, Medical Device Manufacturers, and Others), and Geography
Sep 2019
Ovo-Sexing Technology Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technique (Non-Invasive Imaging, Genetic Editing, Volatile Analysis, Sex Reversal, and Liquid-Based Analysis), End User (Hatcheries and Poultry Farms), and Geography (US, Germany, France, Italy, Spain, Rest of Europe, Israel, and ROW)
Sep 2019
Dental Laser Treatment Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Application (Hard Tissue, Soft Tissue, and Others), End User (Hospitals, Dental Clinics, Dental-Owned Practices, and Others), Clinical Indication [Conservative Dentistry, Root Canal (Endodontic Treatment), Oral Surgery, Implantology, Peri-Implantitis, Periodontics, and Others], and Geography
Sep 2019
Microbiology CRO Services Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Application (Clinical, Medical Device, and Others), Service Type (Assay Development, Custom Viral Stock Production, Microbial Testing, and Others), Microorganisms (Bacteria, Fungi, Viruses, and Parasites), End User (Biotech and Pharmaceutical Companies, Medical Device Companies, and Others), and Geography
Sep 2019
Antimicrobial Surgical Suture Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Triclosan Antimicrobial Suture and Chlorhexidine Antimicrobial Suture), Raw Materials (Polyglactin 910 Antimicrobial Suture, Poliglecaprone 25, and Polyglycolic Acid), Application (Cardiovascular Surgery, General Surgery, Ophthalmic Surgery, Gynecological Surgery, Orthopedic Surgery, Plastic Surgery, Veterinary Surgery, Dental Surgery, and Others), End User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2019
Organoids Services Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Intestine, Liver, Stomach, Pancreas, Lung, Brain, Kidney, and Others), Application (Developmental Biology Disease, Pathology of Infectious Disease, Regenerative Medicine, Drug Toxicity & Efficacy Testing, Drug Discovery & Personalized Medicine, and Others), Source (Pluripotent Stem Cells and Organ Specific Adult Stem Cell), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2019
Smart Hospital Beds Market
Size and Forecast (2020–2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Patient Weight (Less than 70 lb, 70 to 150 lb, 150 to 400 lb, 400 to 500 lb, Greater than 500 lb); Offering (Products and Accessories, Software and Solutions, and Services); Application (Fall Prevention, Pressure Injury Prevention, Patient Deterioration and Monitoring, and Others); End User (Hospitals, Clinics and Nursing Homes, Ambulatory Surgical Centers, Medical Laboratories, Long Term Care Centers, and Others), and Geography
Sep 2019
Infectious Disease Therapeutics Market
Size and Forecast (2020–2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Drug Class (Anti-viral, Anti Bacterial, Anti-Fungal, and Others), Indication (HIV, Hepatitis, Tuberculosis, Influenza, HPV, and Others), Route of Administration (Oral, Parenteral, Topical, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others), and Geography
Get Free Sample For